In charge of transforming the Monterrey-based family business of dermatological distribution into a Mexican corporate success story, Carlos de Kruyff, shares some of his most pertinent insights on the industry. He speaks about the company’s history and innovative commercialization scheme, the transformative regulatory landscape today, as well as their role in improving the Mexican population’s health literacy regarding proper skin care.
Mr. De Kruyff, you have spearheaded CDM Labs for the last two years, but have had over 20 years of experience in the pharmaceutical industry. Could you please provide an introduction and a background of the company, as well as of yourself to our global executive readers?
"One of the main risks that a distributor faces is the possibility that the multinational companies that they represent open a subsidiary in the country once their products gain critical mass. Therefore, it is in our best interests to have a diverse line of products to spread the level of sales accordingly and minimize our risks."
